Literature DB >> 31184363

Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze?

Diana L Franco1, Benjamin Click1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31184363     DOI： 10.1093/ibd/izz114

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  2 in total

Review 1.  Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review.

Authors:  Silvia Marquez-Megias; Ricardo Nalda-Molina; Javier Sanz-Valero; Patricio Más-Serrano; Marcos Diaz-Gonzalez; Maria Remedios Candela-Boix; Amelia Ramon-Lopez
Journal:  Pharmaceutics       Date:  2022-05-07       Impact factor: 6.525

Review 2.  Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues.

Authors:  Laurent Peyrin-Biroulet; William J Sandborn; Remo Panaccione; Eugeni Domènech; Lieven Pouillon; Britta Siegmund; Silvio Danese; Subrata Ghosh
Journal:  Therap Adv Gastroenterol       Date:  2021-12-09       Impact factor: 4.409
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.